DR MORERE
ActiveSummary
DR MORERE has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €124,934 and a net result of €85,983. Equity is growing by ~26.6% per year across the filed fiscal years. Its solvency ranks better than 31% of 19922 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability100▲+7
Solvency71▼-29
Growth78=
Track record100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €9,000 at 30 days acceptable
Liquidity ample (current ratio 1.69 against 6.94 in 2023; short-term debt: 51.8% and cash: 12.7% of total assets), but 54.2% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-08-2025, 29 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 5 filingsDeviation from the deadline
2025
not confirmed
2024
29 d late
2023
61 d late
2022
31 d late
2021
19 d early
2020
20 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 5 accounts on average 24 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, micro schema
Equity
€124,934▼ 16.7%
2023 · €149,951
Total assets
€272,602▲ 44.5%
2023 · €188,664
Net result
€85,983▲ 136%
2023 · €36,392
Working capital
€96,694▼ 23.1%
2023 · €125,758
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€17,571-€104,070▲ 492%€13,387▼ 87.1%€46,722▲ 249%€104,905▲ 125%
Net result€13,695below the sector's middle half-€83,082within the sector's middle half▲ 507%€11,782below the sector's middle half▼ 85.8%€36,392within the sector's middle half▲ 209%€85,983within the sector's middle half▲ 136%
Equity€18,695below the sector's middle half-€101,777within the sector's middle half▲ 444%€113,559within the sector's middle half▲ 11.6%€149,951within the sector's middle half▲ 32.0%€124,934within the sector's middle half▼ 16.7%
Total assets€27,148below the sector's middle half-€153,737within the sector's middle half▲ 466%€155,632within the sector's middle half▲ 1.2%€188,664within the sector's middle half▲ 21.2%€272,602within the sector's middle half▲ 44.5%
Debt€8,453-€51,960▲ 515%€42,073▼ 19.0%€38,713▼ 8.0%€147,668▲ 281%
Working capital€13,785below the sector's middle half-€88,804within the sector's middle half▲ 544%€90,736within the sector's middle half▲ 2.2%€125,758within the sector's middle half▲ 38.6%€96,694within the sector's middle half▼ 23.1%
Solvency68.9%within the sector's middle half-66.2%within the sector's middle half▼ 2.7pp73.0%within the sector's middle half▲ 6.8pp79.5%within the sector's middle half▲ 6.5pp45.8%within the sector's middle half▼ 33.7pp
Current ratio2.90within the sector's middle half-8.01above the sector's middle half▲ 5.117.67above the sector's middle half▼ 0.346.94above the sector's middle half▼ 0.731.69within the sector's middle half▼ 5.26
Return on assets (ROA)50.4%above the sector's middle half-54.0%above the sector's middle half▲ 3.6pp7.6%below the sector's middle half▼ 46.5pp19.3%within the sector's middle half▲ 11.7pp31.5%within the sector's middle half▲ 12.3pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed two years in a row; 2024 is 125% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €272,602
Fixed assets
€34,784 ▼ 16.7%
Current assets
€237,817 ▲ 61.9%
Equity and liabilities €272,602
Equity
€124,934 ▼ 16.7%
Debt
€147,668 ▲ 281%
Debt's share of the balance-sheet total rises from 20.5% to 54.2%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€118,514▲
2023 · €59,712
Cash flow
€99,593▲
2023 · €49,382
Debt to equity
1.18▲
2023 · 0.26
ROE
68.8%▲
2023 · 24.3%
Interest coverage
256.01▲
2023 · 171.56
Debt ≤ 1 year
€141,124▲
2023 · €21,155
Debt > 1 year
€5,544▼
2023 · €16,558
Income taxes
€25,353▲
2023 · €11,187
Staff costs
€0▼
2023 · €128
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 26,975 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 95% are still going.
- Micro
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
1.6%
went bankrupt
3.4%
stopped otherwise
95%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.3% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 26,975 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | - | - | €128 | €0 | ▼ 100% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1,317 | €8,181 | €13,528 | €12,990 | €13,610 | ▲ 4.8% |
| Other operating charges640/8 | - | €649 | €1,060 | €721 | €348 | ▼ 51.6% |
| Gross operating margin9900 | €18,988 | €112,900 | €27,975 | €60,560 | €118,863 | ▲ 96.3% |
| Operating profit (loss)9901 | €17,571 | €104,070 | €13,387 | €46,722 | €104,905 | ▲ 125% |
| Financial income75/76B | - | €1,039 | €2,738 | €1,205 | €6,894 | ▲ 472% |
| Recurring financial income75 | €0 | €1,039 | €2,738 | €1,205 | €6,894 | ▲ 472% |
| Financial charges65/66B | - | €350 | €445 | €348 | €463 | ▲ 33.0% |
| Recurring financial charges65 | €221 | €350 | €445 | €348 | €463 | ▲ 33.0% |
| Profit (loss) for the period before taxes9903 | €17,350 | €104,759 | €15,680 | €47,579 | €111,336 | ▲ 134% |
| Income taxes67/77 | €3,655 | €21,678 | €3,899 | €11,187 | €25,353 | ▲ 127% |
| Profit (loss) for the period9904 | €13,695 | €83,082 | €11,782 | €36,392 | €85,983 | ▲ 136% |
| Profit (loss) for the period to be appropriated9905 | €13,695 | €83,082 | €11,782 | €36,392 | €85,983 | ▲ 136% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €27,148 | €153,737 | €155,632 | €188,664 | €272,602 | ▲ 44.5% |
| Fixed assets21/28 | €6,110 | €52,263 | €51,295 | €41,751 | €34,784 | ▼ 16.7% |
| Tangible fixed assets22/27 | €6,110 | €52,263 | €51,295 | €41,751 | €34,304 | ▼ 17.8% |
| Furniture and vehicles24 | - | €52,263 | €39,215 | €27,925 | €21,221 | ▼ 24.0% |
| Other tangible fixed assets26 | - | - | €12,080 | €13,826 | €13,084 | ▼ 5.4% |
| Financial fixed assets28 | - | - | - | - | €480 | - |
| Current assets29/58 | €21,038 | €101,474 | €104,337 | €146,913 | €237,817 | ▲ 61.9% |
| Amounts receivable after more than one year29 | - | €28,333 | €90,225 | €90,225 | €92,682 | ▲ 2.7% |
| Other amounts receivable291 | - | €28,333 | €90,225 | €90,225 | €92,682 | ▲ 2.7% |
| Amounts receivable within one year40/41 | €4,803 | €4,259 | €7,146 | €45,583 | €109,226 | ▲ 140% |
| Trade receivables40 | - | €937 | €3,824 | €0 | €16,425 | - |
| Other amounts receivable41 | - | €3,322 | €3,322 | €45,583 | €92,801 | ▲ 104% |
| Cash at bank and in hand54/58 | €16,062 | €66,827 | €5,333 | €9,455 | €34,688 | ▲ 267% |
| Deferred charges and accrued income490/1 | - | €2,055 | €1,632 | €1,650 | €1,221 | ▼ 26.0% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €27,148 | €153,737 | €155,632 | €188,664 | €272,602 | ▲ 44.5% |
| Equity10/15 | €18,695 | €101,777 | €113,559 | €149,951 | €124,934 | ▼ 16.7% |
| Contributions10/11 | - | €5,000 | €5,000 | €5,000 | €5,000 | = |
| Profit (loss) carried forward14 | €13,695 | €96,777 | €108,559 | €144,951 | €119,934 | ▼ 17.3% |
| Amounts payable17/49 | €8,453 | €51,960 | €42,073 | €38,713 | €147,668 | ▲ 281% |
| Amounts payable after more than one year17 | - | €38,289 | €27,472 | €16,558 | €5,544 | ▼ 66.5% |
| Financial debts170/4 | - | €38,289 | €27,472 | €16,558 | €5,544 | ▼ 66.5% |
| Amounts payable within one year42/48 | €7,253 | €12,670 | €13,601 | €21,155 | €141,124 | ▲ 567% |
| Current portion of amounts payable after more than one year42 | - | €10,720 | €10,817 | €10,915 | €11,014 | ▲ 0.9% |
| Trade debts44 | €24 | - | - | €2,669 | €1,372 | ▼ 48.6% |
| Suppliers440/4 | - | - | - | €2,669 | €1,372 | ▼ 48.6% |
| Taxes, remuneration and social security45 | - | €1,950 | €2,784 | €7,572 | €17,738 | ▲ 134% |
| Taxes450/3 | - | €1,950 | €2,784 | €7,572 | €17,738 | ▲ 134% |
| Other amounts payable47/48 | - | - | - | - | €111,000 | - |
| Accrued charges and deferred income492/3 | - | €1,000 | €1,000 | €1,000 | €1,000 | = |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €13,695 | €83,082 | €11,782 | €36,392 | €85,983 | ▲ 136% |
| + Depreciation and write-downs630 | €1,317 | €8,181 | €13,528 | €12,990 | €13,610 | ▲ 4.8% |
| Operating cash flow (approximation) | €15,012 | €91,263 | €25,310 | €49,382 | €99,593 | ▲ 102% |
| Investment in fixed assets (approximation) | - | -€54,334 | -€12,560 | -€3,445 | -€6,643 | ▼ 92.8% |
| Change in cash | - | €50,765 | -€61,494 | €4,122 | €25,234 | ▲ 512% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
31-12
Financial
Highest result since 2020net €85,983 ▲136%
Operating result €104,905, net result €85,983, both a record.
30-09
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 61 days late
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
31-12
Financial
Weakest financial yearnet €11,782 ▼85.8%
Net result drops to €11,782, the lowest in the series; recovery starts the following year.
12-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Liquidity triplescurrent ratio 8.01
Current ratio from 2.90 to 8.01.
31-12
Financial
Equity above €100,000Eq €101,777 ▲444%
2 profitable years in a row build equity to €101,777.
20-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 20 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Lambrechts-Woluwe · 1 establishment unit since 2019
Ground area
631 m²
Building footprint
234 m²
Volume, LiDAR
2,748 m³
2 parcels, Brussels · tallest building 17.4 m, ±5 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
DR MORERE
since 20192.296.046.715
2 parcels
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21674C0311/00V003 | Brussels | 386 m² | 1 · 110 m² | 13.0 m · 4 fl. |
| 21363B0333/00N007 | Brussels | 245 m² | 1 · 124 m² | 17.4 m · 5 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
KAKKOS EFTAXIA
BE 0663.922.537
Chaudfontaine · Eq €124,901
Dansanté
BE 1004.216.155
Schaarbeek · Eq €124,990
MEDINVEST
BE 0746.784.390
Mouscron · Eq €125,019
Dr. Sara Willems
BE 0658.889.326
Gent · Eq €125,064
DOCTEUR GAUTHIER VANMUNSTER
BE 1014.974.445
Anthisnes · Eq €124,779
Of 16,629 companies in sector 86220 we hold annual accounts for 7,986. 6,594 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded18-11-2019
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0737795559
Also
9925:BE0737795559
Registered
24-11-2023
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.